CCO Oncology Podcast
A podcast by Clinical Care Options
189 Episoade
-
Treatment Options for Patients With Multiple Myeloma After First Relapse
Publicat: 14.07.2021 -
Precision Medicine in Gynecologic Cancers: Expert Answers to Your Questions
Publicat: 12.07.2021 -
Expert Answers to Questions on Managing Neurofibromatosis Type 1 and MEK Inhibitors for NF1-Associated Plexiform Neurofibromas
Publicat: 12.07.2021 -
Expert Answers to Questions on PARP Inhibitor Combinations in Prostate Cancer
Publicat: 30.06.2021 -
Immunotherapy for Advanced HCC: Current Options and Expert Answers to Clinician Questions
Publicat: 29.06.2021 -
Expert Insight on Key Data From ASCO 2021 Informing Treatment for Endometrial, Ovarian, and Cervical Cancer
Publicat: 24.06.2021 -
Optimizing Therapy for Relapsed/Refractory Multiple Myeloma: Expert Answers to Your Questions
Publicat: 17.06.2021 -
Experts Answer FAQs on Biomarker-Driven Therapy for Non-Small-Cell Lung Cancer
Publicat: 19.05.2021 -
Congress to Clinic: Post-ELCC Updates on Antibody–Drug Conjugates in NSCLC
Publicat: 18.05.2021 -
Immunotherapy for Advanced HCC: Case Series
Publicat: 17.05.2021 -
Incorporating Immune Checkpoint Inhibitors Into Practice for Advanced Urothelial Cancer: Expert Perspectives From Germany
Publicat: 13.05.2021 -
Managing Toxicities Associated With FGFR Inhibitors in Urothelial Cancer and Beyond
Publicat: 04.05.2021 -
Optimizing the Timing and Sequencing of Regorafenib and TAS-102 for Patients With Metastatic Colorectal Cancer
Publicat: 28.04.2021 -
Expert Answers to Questions on Contemporary Management of Multiple Myeloma
Publicat: 22.04.2021 -
Combining PARP inhibitors With Other Treatments for Men With Prostate Cancer: Clinical Trial Updates
Publicat: 19.04.2021 -
Rationale for Combining PARP Inhibitors With Other Therapies in Prostate Cancer
Publicat: 15.04.2021 -
Expert Insight on Key Data From SGO 2021 Informing Treatment for Endometrial and Ovarian Cancer
Publicat: 06.04.2021 -
Expert Answers to Questions on PARP Inhibition for Prostate Cancer
Publicat: 06.04.2021 -
Expert Insights on Highlights From ASH 2020 on Lymphomas/CLL
Publicat: 26.03.2021 -
Improving Outcomes in EGFR-Mutated Non-Small-Cell Lung Cancer: Global Insights on Evolving Practice Standards
Publicat: 25.03.2021
Updates on new data and best practices in the care of patients with cancer across a wide variety of solid tumors and hematologic malignancies from Clinical Care Options. Gain practical clinical insights and strategies and earn CME/CE credit for selected episodes.
